iLIVER
| Abbreviation |
| ISSN | 2772-9478 |
| Publication Information | Publisher: Elsevier Ltd，Publishing cycle: ，Journal Type: journal，Open Access Journals: No |
| Basic data | Year of publication: 2022，Proportion of original research papers: ，Self Citation Rate:， Gold OA Rate: |
Journal Citation Format
Those examples are references to articles in scholarly journals and how they are supposed to appear in your bibliography.
Not all journals organize their published articles in volumes and issues, so these fields are optional. Some electronic journals do not provide a page range, but instead list an article identifier. In a case like this it's safe to use the article identifier instead of the page range.
A journal article with 1 author
A journal article with 2 authors
A journal article with 3 authors
A journal article with 5 or more authors
Books Citation Format
Here are examples of references for authored and edited books.
Thesis Citation Format
Web sites Citation Format
Sometimes references to web sites should appear directly in the text rather than in the bibliography.
Patent Citation Format
Staying up late manually editing references? ivySCI automatically matches journals and helps you generate references with a single click.
Click the button below to start a free trial!
Emerging role of natural bioactive compounds in navigating the future of liver disease
2024-12-1
WGCNA Combined with Machine Learning to Explore Potential Biomarkers and Treatment Strategies for Acute Liver Failure, with Experimental Validation
2024-11-1
Comment on “Clinical Outcomes and Histologic Findings of Patients With Hepatocellular Carcinoma With Durable Partial Response or Durable Stable Disease After Receiving Atezolizumab Plus Bevacizumab”
2024-11-1
Reply to Dr. Sun et al.: Female DILI patients need more clinical attention
2024-11-1
New Approaches to the Treatment of Metabolic Dysfunction-Associated Steatotic Liver with Natural Products
2024-11-1
Emerging role of natural bioactive compounds in navigating the future of liver disease
2024-12-1
WGCNA Combined with Machine Learning to Explore Potential Biomarkers and Treatment Strategies for Acute Liver Failure, with Experimental Validation
2024-11-1
Comment on “Clinical Outcomes and Histologic Findings of Patients With Hepatocellular Carcinoma With Durable Partial Response or Durable Stable Disease After Receiving Atezolizumab Plus Bevacizumab”
2024-11-1
Reply to Dr. Sun et al.: Female DILI patients need more clinical attention
2024-11-1
New Approaches to the Treatment of Metabolic Dysfunction-Associated Steatotic Liver with Natural Products
2024-11-1